Back
Zevra Therapeutics Stock Price Chart
Sponsored
ZVRA
Sponsored
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
48
ZVRA
Zevra Therapeutics
Last Price:
$8.58
Seasonality Move:
-0.81%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
The current trend is relatively stagnant and ZVRA is experiencing slight buying pressure.
Zevra Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.49 | Buy |
20-day SMA: | 8.88 | Sell |
50-day SMA: | 8.71 | Sell |
200-day SMA: | 6.61 | Buy |
8-day EMA: | 8.57 | Buy |
20-day EMA: | 8.71 | Sell |
50-day EMA: | 8.57 | Buy |
200-day EMA: | 7.17 | Buy |
Zevra Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 46.6 | Sell |
Chaikin Money Flow: | 66261 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.54 - 9.36) | Sell |
Bollinger Bands (100): | (7.31 - 8.85) | Buy |
Zevra Therapeutics Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Zevra Therapeutics Stock
Is Zevra Therapeutics Stock a Buy?
-
Zevra Therapeutics share price is 8.59 while ZVRA 8-day simple moving average is 8.49, which is a Buy signal.
-
The stock price of ZVRA is 8.59 while Zevra Therapeutics 20-day SMA is 8.88, which makes it a Sell.
-
Zevra Therapeutics 50-day simple moving average is 8.71 while ZVRA share price is 8.59, making it a Sell technically.
-
ZVRA stock price is 8.59 and Zevra Therapeutics 200-day simple moving average is 6.61, creating a Buy signal.
ZVRA Technical Analysis vs Fundamental Analysis
Sell
48
Zevra Therapeutics (ZVRA)
is a Sell
Is Zevra Therapeutics a Buy or a Sell?
-
Zevra Therapeutics stock is rated a SellThe current Zevra Therapeutics [ZVRA] share price is $8.59. The Score for ZVRA is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Zevra Therapeutics Stock Info
Market Cap:
458.5M
Price in USD:
8.59
Share Volume:
138.5K
Zevra Therapeutics 52-Week Range
52-Week High:
9.76
52-Week Low:
4.20
Sell
48
Zevra Therapeutics (ZVRA)
is a Sell
Zevra Therapeutics Share Price Forecast
-
What is the Zevra Therapeutics stock price today?The Zevra Therapeutics stock price is 8.59 USD today.
-
Will ZVRA stock go up or go down?Zevra Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Zevra Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Zevra Therapeutics is overvalued.
Is Zevra Therapeutics Stock a Buy?
-
Zevra Therapeutics share price is 8.59 while ZVRA 8-day exponential moving average is 8.57, which is a Buy signal.
-
The stock price of ZVRA is 8.59 while Zevra Therapeutics 20-day EMA is 8.71, which makes it a Sell.
-
Zevra Therapeutics 50-day exponential moving average is 8.57 while ZVRA share price is 8.59, making it a Buy technically.
-
ZVRA stock price is 8.59 and Zevra Therapeutics 200-day simple moving average is 7.17, creating a Buy signal.
Fundamental Analysis of Zevra Therapeutics
Is Zevra Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.75 per share, and an increase next year of $1.62 per share.
Technical Analysis of Zevra Therapeutics
Should I short Zevra Therapeutics stock?
-
ZVRA Moving Average Covergence Divergence (MACD) indicator is -0.09, suggesting Zevra Therapeutics is a Sell
-
Zevra Therapeutics Relative Strength Index (RSI) is 46.6, which suggest Zevra Therapeutics is oversold
-
The Bollinger Bands (25) for Zevra Therapeutics is (8.54 - 9.36), which suggest Zevra Therapeutics is a Buy
-
The Bollinger Bands (100) for Zevra Therapeutics is (7.31 - 8.85), which suggest Zevra Therapeutics is a Buy
* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.